Replimune Inc, based in Woburn, is at the forefront of developing a groundbreaking category of tumor-targeted oncolytic immunotherapies.
Their innovative treatments aim to achieve remarkable outcomes for challenging cancer types, offering new hope for patients facing difficult-to-treat malignancies.
Generated from their website's infomation